Inside the Seattle lecture room where experts are brainstorming the future of psychedelic research

Scientists, doctors, advocacy workers, and other community members gathered to discuss the next frontier of treating substance-use disorders and addiction: psychedelics. The meeting was convened by the Center for Novel Therapeutics in Addiction Psychiatry led by Nathan Sackett, MD and was sponsored, in part, by the Garvey Institute for Brain Health Solutions.